Ken Blount

Company: Rebiotix, A Ferring Company

Job title: Chief Scientific Officer

Seminars:

Workshop A – Defining a Strategic Roadmap for Transitioning from Successful Clinical Trials to Regulatory Approval: Phase Appropriate Regulatory Strategy 8:30 am

With regulatory approval and commercialization pivotal milestones in the microbiome drug development journey, join this workshop to benchmark best practices and engage in discussions to address: Designing a Phase-Appropriate Regulatory Strategy: Explore the strategic roadmap for transitioning from successful clinical trials to regulatory approval, focusing on key considerations at each stage of drug development Regulatory…Read more

day: Workshop Track 1